Yahoo Web Search

Search results

1. • 

     Gaston 6-year-old to have the summer of her life while fighting cancer

     The Gaston Gazette via Yahoo News· 1 day ago

     A Gaston family is seeking solace in the community as six-year-old Harmony Nicholson’s months-long...

2. • 

     12-year-old beats rare brain cancer but after 3 years remission is now battling a new form of brain...

     WZZM 13 Grand Rapids· 2 days ago

     Nearly six years ago, now 12-year-old Emerson Hoogendoorn was diagnosed with diffuse midline glioma,...

3. • 

     Gene therapy offers huge potential for combating disease, doctors say

     United Press International via Yahoo News· 6 days ago

     Researchers are engineering ways to alter genes or swap flawed ones with healthy replacements,...

4. • New research platform assesses brain cancer mutations during surgery

     Medical Xpress· 1 week ago

     Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published in Proceedings ...

5. • 

     June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge

     InvestorPlace· 1 day ago

     Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the...

6. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 3 days ago

     IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies, presented encouraging preliminary clinical data of INB-200 at ...

7. • 

     Community supports 12-year-old cancer patient who ‘beat the unbeatable’

     WOOD via Yahoo News· 3 days ago

     Emerson Hoogendoorn's loved ones say she can be described in many words: kind, strong, giving. But...

8. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 5 days ago

     Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of

9. • 

     Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study

     Zacks via Yahoo Finance· 2 days ago

     Data from a late-stage study shows that transfusion-dependent thalassemia patients who received...

10. • Researchers create 'chameleon' compound that targets drug-resistant brain cancers

      Medical Xpress· 3 days ago

      The research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target an array of pernicious ...